Filtered By:
Condition: Bleeding
Education: Study
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 7778 results found since Jan 2013.
Phenotypes and outcomes in non-anticoagulated patients with atrial fibrillation: An unsupervised cluster analysis
CONCLUSION: Cluster analysis identified three statistically driven groups of patients with atrial fibrillation, with distinct phenotype characteristics and associated with different risks for major clinical adverse events.PMID:37422421 | DOI:10.1016/j.acvd.2023.06.001
Source: Archives of Cardiovascular Diseases - July 8, 2023 Category: Cardiology Authors: Arnaud Bisson Ameenathul M Fawzy Giulio Francesco Romiti Marco Proietti Denis Angoulvant Wahbi El-Bouri Gregory Y H Lip Laurent Fauchier Source Type: research
Risk of arterial thromboembolism, bleeding and mortality in atrial fibrillation patients with comorbid cancer: a systematic review and meta-analysis
CONCLUSION: In AF patients, the presence of cancer is associated with a similar risk of TE and an increased risk of bleeding and all-cause death.PMID:37414144 | DOI:10.1016/j.hjc.2023.06.005
Source: Hellenic Journal of Cardiology - July 6, 2023 Category: Cardiology Authors: Charalampos Balomenakis Andreas S Papazoglou Dimitra Vlachopoulou Anastasios Kartas Dimitrios V Moysidis Ioannis Vouloagkas Christos Tsagkaris Konstantinos Georgopoulos Athanasios Samaras Efstratios Karagiannidis George Giannakoulas Source Type: research
Bioprosthetic versus mechanical valves for mitral valve replacement in patients & lt; 70 years: an updated pairwise meta-analysis
ConclusionThe use of MMV in patients < 70 undergoing MVR is associated with lower rates of 30-day/long-term mortality compared to BPV. No significant differences were observed for risk of 30-day/long-term stroke, long-term reoperation, and long-term major bleeding. These findings support the use of MMV in younger patients, although pr ospective, randomized trials are still needed.
Source: General Thoracic and Cardiovascular Surgery - July 6, 2023 Category: Cardiovascular & Thoracic Surgery Source Type: research
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial
ConclusionsTherapeutic anticoagulation with rivaroxaban compared to prophylactic anticoagulation with a heparin did not improve surrogates of clinical outcome in patients with moderate to severe COVID-19. Whether initial rivaroxaban at therapeutic doses might be superior to thromboprophylaxis in patients with COVID-19 and a high risk as defined byd-dimer > 2 ULN needs confirmation in further studies.Graphical abstract
Source: Clinical Research in Cardiology - July 5, 2023 Category: Cardiology Source Type: research
Hemorrhagic risk factors after rt PA thrombolysis in acute cerebral infarction
CONCLUSIONS: The establishment of a prediction model based on the risk factors of HT after rt-PA thrombolysis had a good predictive value in patients with ACI. This model was helpful in guiding clinical judgment and improving the safety of intravenous thrombolysis. Early identification of symptomatic bleeding risk factors provided a reference for clinical treatment and prognostic measures of patients with ACI.PMID:37401290 | DOI:10.26355/eurrev_202306_32791
Source: European Review for Medical and Pharmacological Sciences - July 4, 2023 Category: Drugs & Pharmacology Authors: L Liu G-Q Luo Q Liu Z-Y Yang Source Type: research
